Walgreens Boots Alliance is considering options including a sale of its Shields Health Solutions specialty pharmacy unit, Bloomberg’s Michelle Davis, Ryan Gould, and Dinesh Nair report, citing people familiar with the matter. The unit could be valued at over $4B in a sale, the authors say, noting that the company is working with advisers to gauge interest in the business.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on WBA:
- Walgreens Boots Alliance price target lowered to $25 from $27 at Truist
- Walgreens agrees to pay $360M to Humana to settle pricing dispute, WSJ reports
- Walgreens Stock (NASDAQ:WBA): Dividend Slashed after 47 Years. Blessing in Disguise?
- Walgreens Boots Alliance Inc. Earnings Update: Did it Beat Estimate Forecasts?
- Walgreens Stock (NASDAQ:WBA): Consider Taking Action on the Market’s Wrong Reaction
